Cardiol Therapeutics | WebDisclosure

Basculer en Français

11046	Companies
242130	Keywords
170518	Articles
130355	Press releases

Home
Companies
Cardiol Therapeutics

PRESS RELEASE

published on 04/23/2025 at 15:24, 1 year 4 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation for Cardiol Therapeutics Inc, maintaining Buy rating and USD 8.50 target price. CardiolRxT phase III study enrollment for recurrent pericarditis (RP) shows promise for FDA approval

FDA Approval Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating CardiolRxT
BRIEF

published on 11/22/2024 at 11:11, 1 year 10 months ago

Cardiol Therapeutics obtient une note d'achat suite à des résultats d'essais prometteurs

Essais Cliniques Acheter Une Note CardiolRx Thérapeutique Cardiol Efficacité Des Médicaments
BRIEF

published on 11/22/2024 at 11:11, 1 year 10 months ago

Cardiol Therapeutics Secures Buy Rating Amid Promising Trial Results

Clinical Trials BUY Rating Cardiol Therapeutics CardiolRx Drug Efficacy
PRESS RELEASE

published on 11/22/2024 at 11:06, 1 year 10 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research reaffirms BUY rating for Cardiol Therapeutics Inc. with USD8.50 price target based on positive final data for CardiolRx in treating recurrent pericarditis

Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating Reaffirmed CardiolRx
BRIEF

published on 10/28/2024 at 15:51, 1 year 10 months ago

Cardiol Therapeutics lance un essai clinique de phase II/III pour la péricardite récurrente

Essai Clinique CardiolRx Péricardite Récurrente Thérapeutique Cardiol Essai MAVERIC-2
BRIEF

published on 10/28/2024 at 15:51, 1 year 10 months ago

Cardiol Therapeutics Initiates Phase II/III Clinical Trial for Recurrent Pericarditis

Clinical Trial Cardiol Therapeutics CardiolRx Recurrent Pericarditis MAVERIC-2 Trial
PRESS RELEASE

published on 10/28/2024 at 15:46, 1 year 10 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc., initiating phase II/III clinical trial for recurrent pericarditis treatment with CardiolRx

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Clinical Trial Pericarditis Treatment
BRIEF

published on 06/14/2024 at 14:57, 2 years 3 months ago

Cardiol Therapeutics Inc reçoit une note « d'achat » mise à jour de la part de First Berlin Equity Research

Acheter Une Note CardiolRx Cardiol Thérapeutique Péricardite Récurrente Étude De Phase II
BRIEF

published on 06/14/2024 at 14:57, 2 years 3 months ago

Cardiol Therapeutics Inc Receives Updated 'Buy' Rating from First Berlin Equity Research

BUY Rating Cardiol Therapeutics CardiolRx Recurrent Pericarditis Phase II Study
PRESS RELEASE

published on 06/14/2024 at 14:52, 2 years 3 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research increases Cardiol Therapeutics Inc's price target to USD8.50 in Buy recommendation after positive results from phase II trial of CardiolRx for recurrent pericarditis treatment

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Phase II Trial CardiolRx

Accesswire

Published on 09/22/2026 at 13:30, 10 minutes ago

Silver X Increases Measured and Indicated Resources 173% to 10.4 Mt at 213 g/t AgEq (70.8 Moz AgEq) and Inferred Resources 43% to 21.6 Mt at 252 g/t AgEq (180.9 Moz AgEq)
Published on 09/22/2026 at 13:30, 10 minutes ago

Nextech3D.ai Launches "KATE" Training Intelligence Platform, Expanding AI SaaS Strategy and Pursues Participation in Anthropic's Claude Partner Network
Published on 09/22/2026 at 13:23, 17 minutes ago

SLAM Uncovers Antimony, Gold and Silver on Its Moose Lake Trenching Program
Published on 09/22/2026 at 13:00, 40 minutes ago

First Canadian Graphite achève la phase II de son levé aérien
Published on 09/22/2026 at 13:00, 40 minutes ago

First Canadian Graphite Completes Phase II Airborne Survey

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 13:23, 16 minutes ago

Custodian Property Income REIT plc: Interim dividend
Published on 09/22/2026 at 13:15, 25 minutes ago

voestalpine sets clear growth targets in attractive future markets
Published on 09/22/2026 at 13:00, 40 minutes ago

Galimedix announces participation at fall 2026 investor, partnering, and scientific conferences
Published on 09/22/2026 at 12:40, 1 hour ago

CHiQ Sponsors Cologne Junior Wheelchair Tennis Open, Deepening Its Commitment to Community Sports
Published on 09/22/2026 at 12:30, 1 hour 10 minutes ago

WIOCC Group Welcomes U.S. International Development Finance Corporation (DFC) as Investor Alongside AFC and Vision Invest to Accelerate Digital Infrastructure Expansion Across Africa

Les Echos

Published on 09/21/2026 at 18:19, 19 hours 21 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 19 hours 21 minutes ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 19 hours 39 minutes ago

Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 19 hours 54 minutes ago

WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 19 hours 54 minutes ago

WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026

View all LES ECHOS COMFI WIRE